Vivo Capital VIII LLC 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII LLC | 2,073,005 5.500% | -200,000 (-8.80%) | Filing |
| 2021-02-18 4:50 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII LLC | 2,273,005 6.600% | 2,273,005 (New Position) | Filing |